Article

Absolute quantitative proteomics guides patient-stratified drug repurposing in clear cell and papillary renal cell carcinoma

2026-07-17

Abstract excerpt

<h4>Background</h4> Renal cell carcinoma (RCC) is a highly heterogeneous disease in which distinct molecular subtypes exhibit characteristic genomic, metabolic, and microenvironmental features that influence therapeutic response. Substantial inter-patient variability exists within each subtype, resulting in markedly different clinical outcomes even among tumours of the same histological category. Proteomics provi...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 62eb3357-de72-5452-bd38-9b0809a8502c
DOI: 10.64898/2026.07.17.738718

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Absolute quantitative proteomics guides patient-stratified drug repurposing in clear cell and papillary renal cell carcinomaDOI 10.64898/2026.07.17.738718Read

Machine Learning-Enhanced Extraction of Protein Signatures of Renal Cell Carcinoma from Proteomics DataSemantic proximity Read

Decoding the Plasma Proteomic Landscape of Clear Cell Renal Cell Carcinoma Reveals Diagnostic and Prognostic Liquid Biopsy BiomarkersSemantic proximity Read

Multiomics in Renal Cell Carcinoma: Current Landscape and Future Directions for Precision MedicineSemantic proximity Read

Spatial distribution of the proteome in human body and cancersSemantic proximity Read

p53 as a Convergent Genetic Modifier in Chronic Kidney Disease: Unifying Genetic Risk and Defining Renal Modulatory DrugsSemantic proximity Read

Pathway centered analysis to guide clinical decision-making in precision medicineSemantic proximity Read

ProTargetMiner as a proteome signature library of anticancer molecules for functional discoverySemantic proximity Read

A renal cell carcinoma tumorgraft platform to advance precision medicineSemantic proximity Read

Integrative multi-omics and drug–response characterization of patient-derived prostate cancer primary cellsSemantic proximity Read

Systematic assessment of transcriptomic and phenotypic biological profiling for mechanism-based hazard assessment using target- annotated reference chemicals in renal proximal tubular epithelial cellsSemantic proximity Read

Proteomic profiling of advanced hepatocellular carcinoma identifies predictive signatures of response to treatmentsSemantic proximity Read

Shifting Beyond Classical Drug Synergy in Combinatorial Therapy through Solubility AlterationsSemantic proximity Read